These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25663465)

  • 1. Questions about XY Wen et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Liu F; Zhang Q
    Tumour Biol; 2015 Feb; 36(2):557-8. PubMed ID: 25663465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis".
    Guo HB; Xiao T
    Tumour Biol; 2014 May; 35(5):5053. PubMed ID: 24449508
    [No Abstract]   [Full Text] [Related]  

  • 3. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
    Wen X; Liu H; Yu K; Liu Y
    Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on Li H et al. "A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma".
    Zhang Q; Li J; Liu F; Li Z
    Tumour Biol; 2015 Jan; 36(1):5-6. PubMed ID: 25416443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
    Wang P; Sun L; Yu L; Wang H
    Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    He S; Xiao Z; Chen L; Xiong S
    Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway.
    Liu Z; Liu Z; Zhang Y; Li Y; Liu B; Zhang K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):211-217. PubMed ID: 28189676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
    Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma.
    Uchibori M; Nishida Y; Nagasaka T; Yamada Y; Nakanishi K; Ishiguro N
    Int J Oncol; 2006 Jan; 28(1):33-42. PubMed ID: 16327977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis.
    Zhu KP; Ma XL; Zhang CL
    Mol Ther; 2017 Oct; 25(10):2383-2393. PubMed ID: 28750740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
    Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
    Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
    Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
    Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
    J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
    Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
    Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
    Jian Y; Tian X; Li B; Zhou Z; Wu X
    Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells.
    Yamanegi K; Yamane J; Kobayashi K; Ohyama H; Nakasho K; Yamada N; Hata M; Fukunaga S; Futani H; Okamura H; Terada N
    Oncol Rep; 2012 Nov; 28(5):1585-90. PubMed ID: 22923031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NPRL2 is an independent prognostic factor of osteosarcoma.
    Gao Y; Wang J; Fan G
    Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.